Effect of telmisartan on levels of IL-1, TNF-α, down-regulated COX-2, MMP-2, MMP-9 and RANKL/RANK in an experimental periodontitis model

Journal of Clinical Periodontology

Volumn 40, Issue 12, 2013, Pages 1104-1111

  Araújo, Aurigena A ^a   Souza, Tatiana O ^a   Moura, Lígia M ^a,b   Brito, Gerly A C ^c   Aragão, Karoline S ^c   Araújo, Lorena S ^a   Medeiros, Caroline A X ^d   Alves, Maria S C F ^a   Araújo Jr , Raimundo F ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b POTIGUAR UNIVERSITY   (Brazil)

^c FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^d DEPARTAMENTO DE FÍSICA   (Brazil)

Author keywords

anti inflammatory; bone loss; periodontitis model; telmisartan

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; GLUTATHIONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; MALONALDEHYDE; MMP2 PROTEIN, RAT; MMP9 PROTEIN, RAT; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PEROXIDASE; PTGS2 PROTEIN, RAT; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TELMISARTAN; TNFRSF11B PROTEIN, RAT; TUMOR NECROSIS FACTOR ALPHA;

ALVEOLAR BONE LOSS; ANIMAL; ANTI-INFLAMMATORY; ARTICLE; COMPARATIVE STUDY; DISEASE MODEL; DOWN REGULATION; DRUG EFFECT; MALE; METABOLISM; OSTEOLYSIS; OXIDATIVE STRESS; PERIODONTITIS; PERIODONTITIS MODEL; RANDOMIZATION; RAT; WISTAR RAT;

ANTI-INFLAMMATORY; BONE LOSS; PERIODONTITIS MODEL; TELMISARTAN;

ALVEOLAR BONE LOSS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BENZIMIDAZOLES; BENZOATES; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GLUTATHIONE; INTERLEUKIN-10; INTERLEUKIN-1BETA; MALE; MALONDIALDEHYDE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OSTEOPROTEGERIN; OXIDATIVE STRESS; PERIODONTITIS; PEROXIDASE; RANDOM ALLOCATION; RANK LIGAND; RATS; RATS, WISTAR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887321410     PISSN: 03036979     EISSN: 1600051X     Source Type: Journal    
DOI: 10.1111/jcpe.12160     Document Type: Article

References (30)

1. Bhatavadekar, N. B., &, Williams, R. C., (2009) Modulation of the host inflammatory response in periodontal disease management: exciting new directions. International Dental Journal 59, 305-308.
2. Cai, H., Griendling, K. K., &, Harrison, D. G., (2003) The vascular NAD(P)H oxidases as therapeutic targets cardiovascular diseases. Trends in Pharmacological Sciences 24, 471-478.
3. Carvalho Rde, S., de Souza, C. M., Neves, J. C., Holanda-Pinto, S. A., Pinto, L. M., Brito, G. A., &, de Andrade, G. M., (2013) Vitamin E does not prevent bone loss and induced anxiety in rats with ligature-induced periodontitis. Archives of Oral Biology 58, 50-8.
4. Cetinkaya, B. O., Keles, G. C., Ayas, B., Sakallioglu, E. E., &, Acikgoz, G., (2007) The expression of vascular endothelial growth factor in a rat model at destruction and healing stages of periodontal disease. Journal of Periodontology 78, 1129-1135.
5. Elavarasu, S., Sekar, S., &, Murugan, T., (2012) Host modulation by therapeutic agents. Journal of Pharmacy & Bioallied Sciences 4 (Suppl. 2), S256-S259.
6. Graves, D. T., Li, J., &, Cochran, D. L., (2011) Inflammation and uncoupling as mechanisms of periodontal bone loss. Journal of Dental Research 90, 143-153.
7. Hamed, A. A., &, Malek, H. A., (2007) Effect of telmisartan in experimentally induced diabetetes mellitus in rats. International Journal of Health Sciences 1, 249-256.
8. Harada, S., &, Takahashi, N., (2011) Control of bone resorption by RANKL-RANK system. Clinical Calcium 21, 1121-1130.
9. Howell, T. H., &, Williams, R. C., (1993) Nonsteroidal antiinflammatory drugs as inhibitors of periodontal disease progression. Critical Reviews in Oral Biology and Medicine 4, 177-196.
10. Kario, K., (2005) Morning surge and variability in blood pressure: a new therapeutic target? Hypertension 45, 485-486.
11. Kendall, C., Ionescu-Matiu, I., &, Dreesman, G. R., (1983) Utilization of the biotin/avidin system to amplify the sensitivity of the enzyme-linked immunosorbent assay (ELISA). Journal of Immunological Methods 56, 329-339.
12. Kusano, K., Miyaura, C., Inada, M., Tamura, T., Ito, A., Nagase, H., Kamoi, K., &, Suda, T., (1998) Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 139, 1338-1345.
13. Leitao, R. F., Ribeiro, R. A., Chaves, H. V., Rocha, F. A., Lima, V., &, Brito, G. A., (2005) Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats. Journal of Periodontology 76, 956-963.
14. de Lima, V., Bezerra, M. M., de Menezes Alencar, V. B., Vidal, F. D., da Rocha, F. A., de Castro Brito, G. A., &, de Albuquerque Ribeiro, R., (2000) Effects of chlorpromazine on alveolar bone loss in experimental periodontal disease in rats. European Journal of Oral Sciences 108, 123-9.
15. Malle, E., Furtmuller, P. G., Sattler, W., &, Obinger, C., (2007) Myeloperoxidase: a target for new drug development? British Journal of Pharmacology 152, 838-854.
16. Nakano, A., Hattori, Y., Aoki, C., Jojima, T., &, Kasai, K., (2009) Telmisartan inhibits cytokine-induced nuclear factor-kappaB activation independently of the peroxisome proliferator-activated receptor-gamma. Hypertension Research 32, 765-769.
17. Nakashima, T., Kobayashi, Y., Yamasaki, S., Kawakami, A., Eguchi, K., Sasaki, H., &, Sakai, H., (2000) Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochemical and Biophysical Research Communications 275, 768-775.
18. Newton, K., &, Dixit, V. M., (2012) Signaling in innate immunity and inflammation. Cold Spring Harbor Perspectives in Biology 4, pii: a006049.
19. Page, R. C., (1999) Milestones in periodontal research and the remaining critical issues. Journal of Periodontal Research 34, 331-339.
20. Ramamurthy, N. S., Rifkin, B. R., Greenwald, R. A., Xu, J. W., Liu, Y., Turner, G., Golub, L. M., &, Vernillo, A. T., (2002) Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines. Journal of Periodontology 73, 726-734.
21. Safieh-Garabedian, B., Poole, S., Allchorne, A., Winter, J., &, Woolf, C. J., (1995) Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. British Journal of Pharmacology 115, 1265-1275.
22. Salvi, G. E., &, Lang, N. P., (2005) Host response modulation in the management of periodontal diseases. Journal of Clinical Periodontology 32 (Suppl. 6), 108-129.
23. Souza, M. H., Troncon, L. E., Cunha, F. Q., &, Oliveira, R. B., (2003) Decreased gastric tone and delayed gastric emptying precede neutrophil infiltration and mucosal lesion formation in indomethacin-induced gastric damage in rats. Brazilian Journal of Medical and Biological Research 36, 1383-1390.
24. Suda, N., Moriyama, K., &, Ganburged, G., (2013) Effect of angiotensin II receptor blocker on experimental periodontitis in a mouse model of Marfan syndrome. Infection and Immunity 81, 182-188.
25. Tian, Q., Miyazaki, R., Ichiki, T., Imayama, I., Inanaga, K., Ohtsubo, H., Yano, K., Takeda, K., &, Sunagawa, K., (2009) Inhibition of tumor necrosis factor-alpha-induced interleukin-6 expression by telmisartan through cross-talk of peroxisome proliferator-activated receptor-gamma with nuclear factor kappaB and CCAAT/enhancer-binding protein-beta. Hypertension 53, 798-804.
26. Tobon-Arroyave, S. I., Isaza-Guzman, D. M., Restrepo-Cadavid, E. M., Zapata-Molina, S. M., &, Martinez-Pabon, M. C., (2012) Association of salivary levels of the bone remodelling regulators sRANKL and OPG with periodontal clinical status. Journal of Clinical Periodontology 39, 1132-1140.
27. Wei, S., Kitaura, H., Zhou, P., Ross, F. P., &, Teitelbaum, S. L., (2005) IL-1 mediates TNF-induced osteoclastogenesis. Journal of Clinical Investigation 115, 282-290.
28. Wienen, W., Hauel, N., Van Meel, J. C., Narr, B., Ries, U., &, Entzeroth, M., (1993) Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277. British Journal of Pharmacology 110, 245-252.
29. Wienen, W., Richard, S., Champeroux, P., &, Audeval-Gerard, C., (2001) Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats. JRAAS 2, 31-36.
30. Williams, R. C., Barnett, A. H., Claffey, N., Davis, M., Gadsby, R., Kellett, M., Lip, G. Y., &, Thackray, S., (2008) The potential impact of periodontal disease on general health: a consensus view. Current Medical Research and Opinion 24, 1635-1643.